A Phase II Clinical Trial to Study the Efficacy and Safe

Project: Research project

Project Details

Description

A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects with High Risk Non-muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy
StatusActive
Effective start/end date3/1/163/30/21

Funding

  • MERCK

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.